Comparative Effects of the Renin–Angiotensin System Blockers on Nonalcoholic Fatty Liver Disease and Insulin Resistance in C57Bl/6 Mice

Inhibition of Renin-Angiotensin System

(2016) Sharma S. Prabhakar   JOURNAL OF INVESTIGATIVE MEDICINE

Randomized Trial of Perindopril, Enalapril, Losartan and Telmisartan in Overweight or Obese Patients with Hypertension

(2013) Sergey V. Nedogoda et al.   CLINICAL DRUG INVESTIGATION

Liver damage is not reversed during the lean period in diet-induced weight cycling in mice

(2013) Sandra Barbosa-da-Silva et al.   HEPATOLOGY RESEARCH

Hepatic glucose sensing is required to preserve β cell glucose competence

(2013) Pascal Seyer et al.   JOURNAL OF CLINICAL INVESTIGATION

Peroxisome Proliferator-Activated Receptors-Alpha and Gamma Are Targets to Treat Offspring from Maternal Diet-Induced Obesity in Mice

(2013) D'Angelo Carlo Magliano et al.   PLoS One

Renin-Angiotensin System Blockers Protect Pancreatic Islets against Diet-Induced Obesity and Insulin Resistance in Mice

(2013) Eliete Dalla Corte Frantz et al.   PLoS One

Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet

(2012) Julio Cesar Fraulob et al.   CLINICAL SCIENCE

Inhibition of Hypothalamic Inflammation Reverses Diet-Induced Insulin Resistance in the Liver

(2012) M. Milanski et al.   DIABETES

Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose

(2011) Todd S. Perlstein et al.   CLINICAL SCIENCE

Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice

(2011) S D Premaratna et al.   INTERNATIONAL JOURNAL OF OBESITY

Up-Regulation of PPAR-γ mRNA Expression in the Liver of Obese Patients: an Additional Reinforcing Lipogenic Mechanism to SREBP-1c Induction

(2011) Paulina Pettinelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The interaction of hepatic lipid and glucose metabolism in liver diseases

(2011) Lars P. Bechmann et al.   JOURNAL OF HEPATOLOGY

Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet

(2010) Vanessa Souza-Mello et al.   CLINICAL SCIENCE

Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model

(2010) R. Scott Rector et al.   JOURNAL OF HEPATOLOGY

Enhancement in liver SREBP-1c/PPAR-α ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion

(2009) Paulina Pettinelli et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Metabolic disturbances in non-alcoholic fatty liver disease

(2009) Christopher D. Byrne et al.   CLINICAL SCIENCE

The Effect of Angiotensin-Converting Enzyme Inhibition Using Captopril on Energy Balance and Glucose Homeostasis

(2009) Annette D. de Kloet et al.   ENDOCRINOLOGY

Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet

(2009) Richard S. Weisinger et al.   PHYSIOLOGY & BEHAVIOR

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

(2008) Yongzhong Wei et al.   JOURNAL OF HEPATOLOGY

Effect of angiotensin converting enzyme inhibitor enalapril on body weight and composition in young rats

(2007) Edson L. Santos et al.   INTERNATIONAL IMMUNOPHARMACOLOGY